These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 34291991)

  • 21. Pattern of cannabis use in ecstasy polydrug users: moderate cannabis use may compensate for self-rated aggression and somatic symptoms.
    Milani RM; Parrott AC; Schifano F; Turner JJ
    Hum Psychopharmacol; 2005 Jun; 20(4):249-61. PubMed ID: 15816011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
    Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
    J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of multitasking on psychological stress reactivity in recreational users of cannabis and MDMA.
    Wetherell MA; Atherton K; Grainger J; Brosnan R; Scholey AB
    Hum Psychopharmacol; 2012 Mar; 27(2):167-76. PubMed ID: 22389081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.
    de Sola Llopis S; Miguelez-Pan M; Peña-Casanova J; Poudevida S; Farré M; Pacifici R; Böhm P; Abanades S; Verdejo García A; Langohr K; Zuccaro P; de la Torre R
    J Psychopharmacol; 2008 Jul; 22(5):498-510. PubMed ID: 18208910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contribution of cannabis and MDMA ("ecstasy") to cognitive changes in long-term polydrug users.
    Dafters RI; Hoshi R; Talbot AC
    Psychopharmacology (Berl); 2004 May; 173(3-4):405-10. PubMed ID: 12955295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endocannabinoids and 3,4-methylenedioxymethamphetamine (MDMA) interaction.
    Sala M; Braida D
    Pharmacol Biochem Behav; 2005 Jun; 81(2):407-16. PubMed ID: 15927242
    [No Abstract]   [Full Text] [Related]  

  • 27. Verbal working memory deficits in current and previous users of MDMA.
    Wareing M; Fisk JE; Murphy P; Montgomery C
    Hum Psychopharmacol; 2004 Jun; 19(4):225-34. PubMed ID: 15181650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cannabis and Ecstasy/MDMA (3,4-methylenedioxymethamphetamine): an analysis of their neuropsychobiological interactions in recreational users.
    Parrott AC; Milani RM; Gouzoulis-Mayfrank E; Daumann J
    J Neural Transm (Vienna); 2007; 114(8):959-68. PubMed ID: 17520319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gender differences in self-reported anxiety, depression, and somatization among ecstasy/MDMA polydrug users, alcohol/tobacco users, and nondrug users.
    Milani RM; Parrott AC; Turner JJ; Fox HC
    Addict Behav; 2004 Jul; 29(5):965-71. PubMed ID: 15219343
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Everyday memory deficits in ecstasy-polydrug users.
    Montgomery C; Fisk JE
    J Psychopharmacol; 2007 Sep; 21(7):709-17. PubMed ID: 17606476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neural correlates of the severity of cocaine, heroin, alcohol, MDMA and cannabis use in polysubstance abusers: a resting-PET brain metabolism study.
    Moreno-López L; Stamatakis EA; Fernández-Serrano MJ; Gómez-Río M; Rodríguez-Fernández A; Pérez-García M; Verdejo-García A
    PLoS One; 2012; 7(6):e39830. PubMed ID: 22768136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurocognitive function in current and ex-users of ecstasy in comparison to both matched polydrug-using controls and drug-naïve controls.
    Hoshi R; Mullins K; Boundy C; Brignell C; Piccini P; Curran HV
    Psychopharmacology (Berl); 2007 Oct; 194(3):371-9. PubMed ID: 17605005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced memory and attention performance in a population-based sample of young adults with a moderate lifetime use of cannabis, ecstasy and alcohol.
    Indlekofer F; Piechatzek M; Daamen M; Glasmacher C; Lieb R; Pfister H; Tucha O; Lange KW; Wittchen HU; Schütz CG
    J Psychopharmacol; 2009 Jul; 23(5):495-509. PubMed ID: 18635709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cognition in novice ecstasy users with minimal exposure to other drugs: a prospective cohort study.
    Schilt T; de Win MM; Koeter M; Jager G; Korf DJ; van den Brink W; Schmand B
    Arch Gen Psychiatry; 2007 Jun; 64(6):728-36. PubMed ID: 17548754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated impulsivity and impaired decision-making in abstinent Ecstasy (MDMA) users compared to polydrug and drug-naïve controls.
    Morgan MJ; Impallomeni LC; Pirona A; Rogers RD
    Neuropsychopharmacology; 2006 Jul; 31(7):1562-73. PubMed ID: 16292322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered response to tryptophan supplementation after long-term abstention from MDMA (ecstasy) is highly correlated with human memory function.
    Curran HV; Verheyden SL
    Psychopharmacology (Berl); 2003 Aug; 169(1):91-103. PubMed ID: 12759801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polysubstance use patterns and novel synthetics: A cluster analysis from three U.S. cities.
    Elliott L; Haddock CK; Campos S; Benoit E
    PLoS One; 2019; 14(12):e0225273. PubMed ID: 31794586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MDMA & cannabis: a mini-review of cognitive, behavioral, and neurobiological effects of co-consumption.
    Schulz S
    Curr Drug Abuse Rev; 2011 Jun; 4(2):81-6. PubMed ID: 21696342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Self-reported psychopathological symptoms in recreational ecstasy (MDMA) users are mainly associated with regular cannabis use: further evidence from a combined cross-sectional/longitudinal investigation.
    Daumann J; Hensen G; Thimm B; Rezk M; Till B; Gouzoulis-Mayfrank E
    Psychopharmacology (Berl); 2004 May; 173(3-4):398-404. PubMed ID: 14722704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cream of the Crop: Clinical Representativeness of Eligible and Ineligible Cannabis Users in Research.
    Rosen AS; Sodos LM; Hirst RB; Vaughn D; Lorkiewicz SA
    Subst Use Misuse; 2018 Oct; 53(12):1937-1950. PubMed ID: 29509060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.